Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease (NAFLD) is a growing global phenomenon, and its damaging effects in terms of cardiovascular disease (CVD) risk are becoming more apparent. NAFLD is estimated to affect around one quarter of the world population and is often comorbid with other metabolic disorders inc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiovascular development and disease 2022-11, Vol.9 (12), p.419
Main Authors: Josloff, Kevan, Beiriger, Jacob, Khan, Adnan, Gawel, Richard J, Kirby, Richard S, Kendrick, Aaron D, Rao, Abhinav K, Wang, Roy X, Schafer, Michelle M, Pearce, Margaret E, Chauhan, Kashyap, Shah, Yash B, Marhefka, Gregary D, Halegoua-DeMarzio, Dina
Format: Article
Language:English
Subjects:
African Americans
Cardiovascular disease
Comorbidity
Coronary heart disease
CVD
Fatty liver
Hispanic Americans
Hypertension
MAFLD
Mortality
NAFLD
Obesity
Review
Risk factors
Type 2 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nonalcoholic Fatty Liver Disease (NAFLD) is a growing global phenomenon, and its damaging effects in terms of cardiovascular disease (CVD) risk are becoming more apparent. NAFLD is estimated to affect around one quarter of the world population and is often comorbid with other metabolic disorders including diabetes mellitus, hypertension, coronary artery disease, and metabolic syndrome. In this review, we examine the current evidence describing the many ways that NAFLD itself increases CVD risk. We also discuss the emerging and complex biochemical relationship between NAFLD and its common comorbid conditions, and how they coalesce to increase CVD risk. With NAFLD's rising prevalence and deleterious effects on the cardiovascular system, a complete understanding of the disease must be undertaken, as well as effective strategies to prevent and treat its common comorbid conditions.
ISSN:2308-3425
2308-3425
DOI:10.3390/jcdd9120419